{"nct_id":"NCT07011745","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-07-16","start_date_type":"ACTUAL","primary_completion_date":"2028-11-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-11-13","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}